NZ276874A - Vaccine for treating chlamydia comprising a major outer membrane protein and lipopolysaccharide preparation from a chlamydia organism - Google Patents

Vaccine for treating chlamydia comprising a major outer membrane protein and lipopolysaccharide preparation from a chlamydia organism

Info

Publication number
NZ276874A
NZ276874A NZ276874A NZ27687494A NZ276874A NZ 276874 A NZ276874 A NZ 276874A NZ 276874 A NZ276874 A NZ 276874A NZ 27687494 A NZ27687494 A NZ 27687494A NZ 276874 A NZ276874 A NZ 276874A
Authority
NZ
New Zealand
Prior art keywords
momp
vaccine
preparation
chlamydia
ebs
Prior art date
Application number
NZ276874A
Other languages
English (en)
Inventor
Marta Iris Sabara
James Evan Sandbulte
Julie Ann Terwee
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NZ276874A publication Critical patent/NZ276874A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NZ276874A 1993-11-03 1994-11-02 Vaccine for treating chlamydia comprising a major outer membrane protein and lipopolysaccharide preparation from a chlamydia organism NZ276874A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14763693A 1993-11-03 1993-11-03
PCT/US1994/012626 WO1995012411A1 (fr) 1993-11-03 1994-11-02 Vaccin et procede de traitement contre les infections a chlamydia

Publications (1)

Publication Number Publication Date
NZ276874A true NZ276874A (en) 1997-11-24

Family

ID=22522314

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ276874A NZ276874A (en) 1993-11-03 1994-11-02 Vaccine for treating chlamydia comprising a major outer membrane protein and lipopolysaccharide preparation from a chlamydia organism

Country Status (7)

Country Link
EP (1) EP0726775A4 (fr)
CN (1) CN1134112A (fr)
AU (1) AU701247B2 (fr)
BR (1) BR9407986A (fr)
CA (1) CA2175081A1 (fr)
NZ (1) NZ276874A (fr)
WO (1) WO1995012411A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2184132C (fr) * 1995-09-21 2011-03-15 Kristina J. Hennessy Vaccin avec adjuvant, pratiquement exempt d'albumine non-hote
US5972350A (en) * 1996-05-06 1999-10-26 Bayer Corporation Feline vaccines containing Chlamydia psittaci and method for making the same
US7459524B1 (en) 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
MXPA01001090A (es) * 1998-07-27 2002-06-04 Connaught Lab Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
NZ512730A (en) * 1998-12-04 2003-12-19 Univ Manitoba A immunization procedure against chlamydia infection using an attenuated bacteria comprsing a plasmid with a major outer membrane protein (MOMP) from chlamydial
ATE463575T1 (de) * 1999-12-22 2010-04-15 Aventis Pasteur Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
WO2001046226A2 (fr) * 1999-12-22 2001-06-28 Aventis Pasteur Limited Antigenes de chlamydia, fragments d'adn correspondants et utilisations de ceux-ci
WO2001046225A2 (fr) * 1999-12-22 2001-06-28 Aventis Pasteur Limited Antigenes anti-chlamydia, fragments d'adn correspondants et leurs utilisations
JP4413617B2 (ja) * 2001-12-12 2010-02-10 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｃｈｌａｍｙｄｉａｔｒａｃｈｏｍａｔｉｓに対する免疫化
CN103068837B (zh) 2010-05-28 2015-06-24 斯匹遐生物技术公司 嵌合momp抗原、方法和使用
CA2976243C (fr) 2015-02-10 2023-10-31 Ohio State Innovation Foundation Plateformes de cellules b activees par chlamydia et methodes associees
JP7086000B2 (ja) * 2015-11-10 2022-06-17 オハイオ・ステート・イノヴェーション・ファウンデーション 体液性親和性の加速に関する方法及び組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271146A (en) * 1979-09-06 1981-06-02 Seawell Albert C Methods of using Chlamydia vaccine for preventing and treating bovine and ovine diseases

Also Published As

Publication number Publication date
CN1134112A (zh) 1996-10-23
AU701247B2 (en) 1999-01-21
BR9407986A (pt) 1996-12-03
CA2175081A1 (fr) 1995-05-11
AU1129795A (en) 1995-05-23
EP0726775A1 (fr) 1996-08-21
WO1995012411A1 (fr) 1995-05-11
EP0726775A4 (fr) 1999-03-31

Similar Documents

Publication Publication Date Title
Rikihisa et al. Western immunoblot analysis of Ehrlichia chaffeensis, E. canis, or E. ewingii infections in dogs and humans
Coleman et al. Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis
Gamazo et al. Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis
Zuerner et al. Characterization of outer membrane and secreted proteins of Leptospira interrogans serovar pomona
Martinez et al. Protection of goats against heartwater acquired by immunisation with inactivated elementary bodies of Cowdria ruminantium
JP5149242B2 (ja) Ｉｎｖａｐｌｅｘワクチンを用いた免疫化により誘導される異種保護
Rockey et al. Protein antigens of Chlamydia psittaci present in infected cells but not detected in the infectious elementary body
Pal et al. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge
AU701247B2 (en) Vaccine and method for treatment of chlamydial infections
JPS62120322A (ja) アイメリア　アセルブリナ免疫原
Jongejan et al. Identification of an immunodominant antigenically conserved 32-kilodalton protein from Cowdria ruminantium
McCaul et al. Antigenic differences between Coxiella burnetii cells revealed by postembedding immunoelectron microscopy and immunoblotting
KR0177510B1 (ko) 에스케리키아 콜리 백신
MISHIMA et al. Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1
Prescott et al. Use of a virulence‐associated protein based enzyme‐linked immunosorbent assay for Rhodococcus equi serology in horses
Campos et al. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.
Wood et al. Enhanced immunogenicity of Renibacterium salmoninarum in chinook salmon after removal of the bacterial cell surface-associated 57 kDa protein
Kooyman et al. Protection in lambs vaccinated with Haemonchus contortus antigens is age related, and correlates with IgE rather than IgG1 antibody
Pal et al. A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge
Champion et al. Immunization with Treponema pallidum endoflagella alters the course of experimental rabbit syphilis
Blanco et al. The antigenic interrelationship between the endoflagella of Treponema phagedenis biotype Reiter and Treponema pallidum Nichols strain. I. Treponemicidal activity of cross-reactive endoflagellar antibodies against T. pallidum.
Senson et al. Production of the 57 kDa major surface antigen by a non-agglutinating strain of the fish pathogen Renibacterium salmoninarum
US5554371A (en) Recombinant vaccine against Lyme disease
Anacker et al. Biological properties of rabbit antibodies to a surface antigen of Rickettsia rickettsii
Rikihisa Protection against murine potomac horse fever by an inactivated Ehrlichia risticii vaccine